Best Practices, LLC

Report suggests key stakeholder communication crucial to maximizing return on clinical trials

Published in Law and Health Weekly, June 3rd, 2006

To maximize return on clinical trial investment, pharmaceutical companies must effectively communicate the results to key stakeholders. Leading pharmaceutical companies coordinate activities to deliver clinical study results with the maximum immediate impact and long-term reinforcement of key messages.

"From Breakthrough to Blockbuster: Best Practices in Communicating Clinical Trial Results" is a benchmarking from leading pharmaceutical research and consulting firm Best Practices, LLC. The report examines how world-class pharmaceutical companies develop and execute strategies for communicating clinical trial results to diverse physician, managed care, investor and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2006-06-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry